Scholars@Duke

DAROL: DARolutamide ObservationaL study patients in nonmetastatic castration-resistant prostate cancer (nmCRPC) patients.

Publication ,  Conference
Yu, EY; Pieczonka, CM; Briganti, A; Murphy, DG; Lebret, T; Luz, M; Suzuki, H; Thiery-Vuillemin, A; Ortiz, JA; Guan, R; Armstrong, AJ
Published in: JOURNAL OF CLINICAL ONCOLOGY
2020

Duke Scholars

Andrew John Armstrong
Author Andrew John Armstrong Medicine, Medical Oncology

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

2020

Volume

38

Issue

15

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Yu, E. Y., Pieczonka, C. M., Briganti, A., Murphy, D. G., Lebret, T., Luz, M., … Armstrong, A. J. (2020). DAROL: DARolutamide ObservationaL study patients in nonmetastatic castration-resistant prostate cancer (nmCRPC) patients. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 38).
Yu, Evan Y., Christopher Michael Pieczonka, Alberto Briganti, Declan G. Murphy, Thierry Lebret, Murilo Luz, Hiroyoshi Suzuki, et al. “DAROL: DARolutamide ObservationaL study patients in nonmetastatic castration-resistant prostate cancer (nmCRPC) patients.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 38, 2020.
Yu EY, Pieczonka CM, Briganti A, Murphy DG, Lebret T, Luz M, et al. DAROL: DARolutamide ObservationaL study patients in nonmetastatic castration-resistant prostate cancer (nmCRPC) patients. In: JOURNAL OF CLINICAL ONCOLOGY. 2020.
Yu EY, Pieczonka CM, Briganti A, Murphy DG, Lebret T, Luz M, Suzuki H, Thiery-Vuillemin A, Ortiz JA, Guan R, Armstrong AJ. DAROL: DARolutamide ObservationaL study patients in nonmetastatic castration-resistant prostate cancer (nmCRPC) patients. JOURNAL OF CLINICAL ONCOLOGY. 2020.

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

2020

Volume

38

Issue

15

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences